Skip to main content
. 2021 May 10;43(1):830–839. doi: 10.1080/0886022X.2021.1906701

Table 3.

Proposed utilization of urinary furosemide and urinary sodium with decreased urine response to FST.

  Urinary furosemide (FEM2)
  FEM high FEM low
Urine Sodium    
 High Sodium Physiology: Consistent preserved proximal tubular function and distal injury preventing sodium reabsorption
Syndrome: This profile would be consistent with kidney injury that has a TAL or distal injury profile
Physiology: Consistent with tubular injury resulting inability to reabsorb sodium or to secrete furosemide
Syndrome: This profile would be consistent with acute tubular injury and acute tubular necrosis
 Low Sodium Physiology: Demonstrates sufficient oxygen transport to the kidney to enable effective bi-directional proximal tubular function as evidenced by sodium reabsorption and furosemide secretion
Syndromes that would show this pathophysiology: decreased effective circulating volume, congestive heart failure, cardiorenal syndrome, central venous congestion
Physiology: Demonstrates sufficient oxygen transport to the kidney to maintain sodium reabsorption but inability to secrete furosemide.
Syndrome: This physiology would be consistent with a profound hypo-albuminemia state and may be indicative of the threshold wherein albumin replacement therapy is indicated